Alfaxalone Alfadolone Mixture
(YYPNLXNMXQFMHG-GSEHKNNPSA-N)
Structure
- SMILES
- O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2C(=O)C[C@]2([C@H]1CC[C@@H]2C(=O)C)C)C.O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]1[C@@H]2C(=O)C[C@]2([C@H]1CC[C@@H]2C(=O)COC(=O)C)C)C
- Molecular Formula:
- C44H66O8
- Molecular Weight:
- 722.990
- Log P:
- 7.0916
- Hydrogen Bond Acceptor:
- 8
- Hydrogen Bond Donor:
- 2
- TPSA:
- 135.04
- CAS Number(s):
- 8067-82-1
Synonym(s)
1.
Alfaxalone Alfadolone Mixture
2.
Alfatesine
3.
Alfathesin
4.
Alphadione
5.
Alphathesin
6.
Althesin
7.
CT-1341
8.
Glaxovet
9.
Saffan
10.
Alfadolone Mixture, Alfaxalone
11.
CT 1341
12.
CT1341
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hypotension | 5115032 | CTD | |
| 2 | Hypovolemia | 999049 | CTD | |
| 3 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Pain, Postoperative | 4696413 | CTD | |
| 5 | Postoperative Complications | 6545097 | CTD | |
| 6 | Postoperative Nausea and Vomiting | 4696413 | CTD | |
| 7 | Respiratory Insufficiency | 5115032 | CTD | |
| 8 | Respiratory Paralysis | 1171057 1171058 | CTD | |
| 9 | Seizures | 6786708 | CTD | |
| 10 | Shock | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Urticaria | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.